Skip to main content
. 2022 Jan 20;11:811941. doi: 10.3389/fonc.2021.811941

Figure 1.

Figure 1

De-regulation of IL-6 and TGF-β in HCC patient datasets. (A) A year-wise timeline analysis showing IL-6 levels in serum/plasma of HCC patients compared to those in healthy control. (B) Analysis of concentration of IL-6 (pg/ml) in HCC patients from three independent studies compared to that in healthy control. (C) A year-wise timeline analysis showing TGF-β levels in serum/plasma of HCC patients compared to those in healthy control. (D) Analysis of concentration of TGF-β levels (ng/ml) in HCC patients compared to that in healthy control from three independent studies.